Company profile

CMR Surgical

Surgical AI & Robotics

Company profile

About CMR Surgical

CMR Surgical is a global medical technology company that has developed the Versius Surgical Robotic System, a next-generation surgical robot designed to expand access to robotic-assisted surgery across all care settings. The company's flagship product, Versius Plus, is a compact, modular, and portable surgical robot that fits into virtually any operating room without requiring dedicated space or infrastructure modifications. Unlike traditional large surgical robots, Versius is designed with adaptability at its core, allowing hospitals to seamlessly switch between robotic and non-robotic procedures in the same space and enabling easy movement between departments and operating rooms. The system supports familiar port placement, allowing surgeons to build on their existing laparoscopic knowledge and rapidly achieve proficiency with surgical robotics. Versius Plus features an integrated fluorescence visualization system called vLimeLite for real-time ICG imaging, a full suite of articulated instruments, and a comprehensive digital ecosystem that includes Versius Connect for surgeons and Versius Team for hospital administrators. These digital tools provide near-real-time procedural data, usage tracking, and operational insights to optimize robotic surgery programs. CMR Surgical has achieved significant clinical adoption, with over 45,000 procedures performed globally, making Versius the second most utilized robotic surgical platform worldwide. The company has received FDA 510(k) clearance for cholecystectomy procedures in the United States and has submitted for gynecology indications. Versius is also approved for use across Europe, Australia, and Brazil. CMR Surgical's approach emphasizes partnership with surgical teams, offering evidence-based implementation support backed by clinical research and a mature digital ecosystem. The company's mission centers on putting patients first in every decision, working to democratize access to the benefits of minimal access surgery through innovative, accessible robotic technology.

Company description CMR Surgical official website

Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at CMR Surgical?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Benign gynecologic conditions
  • Cholecystectomy
  • Colorectal surgery
  • General surgery
  • Minimal access surgery procedures
  • Thoracic surgery

Who it serves

  • Academic Medical Centers
  • Health Systems
  • Hospitals
  • Surgical Centers

Deployment & integration

Cloud Saas · Embedded · On Premise deployment with recorded integration context.

Geographic context

MarketsAustralia · Brazil · Europe · United Kingdom · United States
Company sourceOfficial website

Company milestones

Platform expansion

FDA 510(k) clearance for Versius Plus cholecystectomy (December 2025), 510(k) submission for gynecology indications (April 2026), 45,000 global procedures milestone (March 2026), U.S. market entry (2025-2026)

Partnerships

Recorded partners

  • Association of Surgeons in Training (ASiT)
  • EIZO Corporation (CuratOR product)
  • Institut Curie
  • Milton Keynes University Hospital

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Versius Connect

Near-real-time procedural logbook app for surgeons

Software · Cloud SaaSCompany source

Versius Digital Ecosystem

Comprehensive digital platform for actionable surgical data and insights

Platform · Cloud SaaSCompany source

Versius Plus Surgical Robotic System

Next generation surgical robot for versatile, adaptable robotic-assisted surgery

Device · On PremiseCompany source

Versius Surgical Robotic System

Small, modular & portable surgical robot for minimal access surgery

Device · On PremiseCompany source

Versius Team

Live dashboard for tracking robotic program usage and efficiency

Software · Cloud SaaSCompany source

vLimeLite Visualization System

Integrated fluorescence visualization system with real-time ICG imaging

Device · EmbeddedCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

Preliminary Multicenter Experience With the Versius Robotic Surgical System for Radical Prostatectomy: Oncological Outcomes With a Minimum 18-Month of Follow-Up.

The international journal of medical robotics + computer assisted surgery : MRCAS · Apr 1, 2026

Collagen-Electrohydrodynamic Hierarchical Lithography for Biomimetic Photonic Micro-Nanomaterials.

Small (Weinheim an der Bergstrasse, Germany) · Oct 1, 2024

Partial nephrectomy series using Versius robotic surgical system: technique and outcomes of an initial experience.

Journal of robotic surgery · Feb 13, 2024

Versius robotic surgical system: case series of 18 robot-assisted radical prostatectomies.

BJU international · Feb 1, 2024

Technical and ethical considerations in telesurgery.

Journal of robotic surgery · Jan 17, 2024

New robotic platform for transoral robotic surgery: an IDEAL stage 0 study.

BMJ surgery, interventions, & health technologies · Jan 1, 2024

Clinical validation

Clinical-trial records

Versius Robotic Surgery in the NHS: A Multi-Specialty Retrospective Study

NCT07761299 · Sponsor · NOT YET RECRUITING

Versius Clinical Study in Robot Assisted Inguinal Hernia Repair Surgery

NCT07316517 · Sponsor · NOT YET RECRUITING

Versius Gynecology Study

NCT07289295 · Sponsor · RECRUITING

Post Market Clinical Study to Evaluate the Performance of the Versius Surgical System

NCT07096856 · Sponsor · NOT YET RECRUITING

Prospective Clinical Study to Assess the Safety and Efficacy of Versius, in Transoral Robotic Surgery

NCT06112535 · Sponsor · COMPLETED

Versius Paediatrics Study

NCT06539442 · Sponsor · RECRUITING

Regulatory

Regulatory records

No linked records are currently available.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

45,000+ procedures performed globally

Clinical adoption milestone as of March 2026

Second most utilized robotic surgical platform globally

Market position as of March 2026

Global Healthcare Systems

Deployment of Versius surgical robotic system across multiple procedures and specialties

45,000+ procedures performed globally, second most utilized robotic surgical platform worldwide

Milton Keynes University Hospital

Implementation of Versius robotic surgical system for various procedures

Institut Curie

Introduction of surgical robotics research through clinical studies with Versius

Hospital remains at forefront of innovation with two new clinical studies

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Massimillano Colella

Chief Executive Officer

Mario Nosotti

Thoracic Surgeon

Pradeep Chowbey

General Surgeon

Vanash Patel

Colorectal Surgeon

Steven Le Gouill

Professor

06 · Company updates

Updates from CMR Surgical

Recent articles published on CMR Surgical's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Surgical AI & Robotics

Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon